Clinical Trial Update: Everolimus in Treating Patients With Recurrent Low-Grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of everolimus in adults with recurrent low-grade glioma has completed; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasm
• Diffuse Astrocytoma
• Mixed Glioma
• Oligodendroglioma
• Subependymal Giant Cell Astrocytoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Susan Chang | Conditions: Adult Diffuse Astrocytoma, Adult Mixed Glioma | Phase 2 | Status: COMPLETED | Results posted: 2019-04-25